Association study of the 5-HT2A receptor gene polymorphism, T102C and essential hypertension

被引:26
作者
Liolitsa, D [1 ]
Powell, JF [1 ]
Prince, M [1 ]
Lovestone, S [1 ]
机构
[1] Inst Psychiat, Dept Neurosci, London SE5 8AF, England
关键词
serotonin; essential hypertension; blood pressure; gender; association study;
D O I
10.1038/sj.jhh.1001177
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Serotonin dysfunction has been implicated in hypertension due to its ability to induce vasoconstriction via stimulation of 5-HT2 receptors and due to the antihypertensive effect of ketanserin, an antagonist at the 5-HT2A receptor subtype, expressed both on arteries and the brain, The silent T102C polymorphism in the 5-HT2A gene is in absolute linkage disequilibrium with a polymorphism in the promoter and may contribute to genetic predisposition possibly by modifying the transcription of the gene, Objective: To examine the genetic contribution of the T102C 5-HT2A polymorphism in essential hypertension in a case-control sample of UK residents. Design: The hypertensive group consisted of 342 subjects over 75 years and the community-based control group consisted of 319 subjects, Subjects were genotyped for the T102C polymorphism by Mspl restriction enzyme digestion following PCR amplification. Results: Sex-specific association analysis revealed significant differences between hypertensive and normotensive subjects in the genotypes distribution (P = 0.016) and allelic frequencies (P = 0.007) in the female group, The direction of significance was increased frequency of the 102-C allele in the hypertensive subjects, There were no association between haplotype and age or body mass index, which suggest that the effect of the T102C variant is not influenced by these variables, Conclusion: This data indicates that the T102C polymorphism in the 5-HT2A gene might be an independent risk factor for increased blood pressure in female individuals with essential hypertension.
引用
收藏
页码:335 / 339
页数:5
相关论文
共 34 条
[1]   ASSOCIATION BETWEEN CLOZAPINE RESPONSE AND ALLELIC VARIATION IN 5HT(2A) RECEPTOR GENE [J].
ARRANZ, M ;
COLLIER, D ;
SODHI, M ;
BALL, D ;
ROBERTS, G ;
PRICE, J ;
SHAM, P ;
KERWIN, R .
LANCET, 1995, 346 (8970) :281-282
[2]  
Arranz MJ, 1996, LANCET, V347, P1831
[3]   ANGIOTENSIN-II TYPE-1 RECEPTOR GENE POLYMORPHISMS IN HUMAN ESSENTIAL-HYPERTENSION [J].
BONNARDEAUX, A ;
DAVIES, E ;
JEUNEMAITRE, X ;
FERY, I ;
CHARRU, A ;
CLAUSER, E ;
TIRET, L ;
CAMBIEN, F ;
CORVOL, P ;
SOUBRIER, F .
HYPERTENSION, 1994, 24 (01) :63-69
[4]   Polymorphic imprinting of the serotonin-2A (5-HT2A) receptor gene in human adult brain [J].
Bunzel, R ;
Blümcke, I ;
Cichon, S ;
Normann, S ;
Schramm, J ;
Propping, P ;
Nöthen, MM .
MOLECULAR BRAIN RESEARCH, 1998, 59 (01) :90-92
[5]   Genetic influences on blood pressure with the cold-pressor test: A twin study [J].
Busjahn, A ;
Faulhaber, HD ;
Viken, RJ ;
Rose, RJ ;
Luft, FC .
JOURNAL OF HYPERTENSION, 1996, 14 (10) :1195-1199
[6]   Association analysis of β2 adrenoceptor polymorphisms with hypertension in a Black African population [J].
Candy, G ;
Samani, N ;
Norton, G ;
Woodiwiss, A ;
Radevski, I ;
Wheatley, A ;
Cockcroft, J ;
Hall, IP .
JOURNAL OF HYPERTENSION, 2000, 18 (02) :167-172
[7]   LINKAGE OF THE ANGIOTENSINOGEN GENE TO ESSENTIAL-HYPERTENSION [J].
CAULFIELD, M ;
LAVENDER, P ;
FARRALL, M ;
MUNROE, P ;
LAWSON, M ;
TURNER, P ;
CLARK, AJL .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (23) :1629-1633
[8]   EVIDENCE THAT BLOOD-PRESSURE REDUCTION BY SEROTONIN ANTAGONISTS IS RELATED TO ALPHA-RECEPTOR BLOCKADE IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
COHEN, ML ;
FULLER, RW ;
KURZ, KD .
HYPERTENSION, 1983, 5 (05) :676-681
[9]   Association between 5-HT2A gene promoter polymorphism and anorexia nervosa [J].
Collier, DA ;
Arranz, MJ ;
Li, T ;
Mupita, D ;
Brown, N ;
Treasure, J .
LANCET, 1997, 350 (9075) :412-412
[10]   HYPERSENSITIVITY OF MESENTERIC VEINS TO 5-HYDROXYTRYPTAMINE-INDUCED AND KETANSERIN-INDUCED REDUCTION OF PORTAL PRESSURE IN PORTAL HYPERTENSIVE RATS [J].
CUMMINGS, SA ;
GROSZMANN, RJ ;
KAUMANN, AJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 89 (03) :501-513